First two data centers join Janssen’s European collaborative network

The Janssen (NJ, USA)-led initiative, HONEUR (Hematology Outcomes Network In Europe), has secured it first two data centers, moving them one step closer towards their goal of using real-world data to accelerate research into blood cancer treatments. From the Janssen Pharmaceutical Companies of Johnson & Johnson (Beerse, Belgium), HONEUR (Hematology Outcomes Network In Europe) has been developed to harness the full potential of real-world data and provide answers to research questions that randomized clinical trials cannot. It has been announced that the first two data centers have joined the network — Leicester Royal Infirmary (UK) and The Registry of Monoclonal...